Evidence map›Paper›PMID 31653831›Full record

ArticleNature communications2019

Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology.

Jana K Sonner, Melanie Keil, Maren Falk-Paulsen, Neha Mishra, Ateequr Rehman, Magdalena Kramer, Katrin Deumelandt, Julian Röwe, Khwab Sanghvi, Lara Wolf and 22 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 10 institutions in 4 countries.

Jana K SonnerDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-4700-272X
Melanie KeilDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Maren Falk-PaulsenInstitute of Clinical Molecular Biology, University Kiel, Kiel, Germany.
Neha MishraInstitute of Clinical Molecular Biology, University Kiel, Kiel, Germany.
Ateequr RehmanInstitute of Clinical Molecular Biology, University Kiel, Kiel, Germany.
Magdalena KramerDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katrin DeumelandtDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Julian RöweDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Khwab SanghviDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lara WolfDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Anna von LandenbergDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hendrik WolffMolecular Biotechnology, Department of Biosciences and Buchmann Institute for Molecular Life Sciences (BMLS), Goethe-University Frankfurt, Frankfurt, Germany.
Richa BhartiInstitute of Clinical Molecular Biology, University Kiel, Kiel, Germany.
Iris OezenDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tobias V LanzDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7106-8801
Florian WankeUniversity Medical Center of the Johannes Gutenberg-University Mainz, Institute for Molecular Medicine, Mainz, Germany.
Yilang TangUniversity Medical Center of the Johannes Gutenberg-University Mainz, Institute for Molecular Medicine, Mainz, Germany.ORCID http://orcid.org/0000-0001-7560-8369
Ines BrandaoCenter for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Soumya R MohapatraJunior Group Brain Cancer Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lisa EppingUniversity Hospital Münster, Department of Neurology with Institute of Translational Neurology, 48149, Münster, Germany.
Alexandra GrillCenter for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Ralph RöthnCounter Core Facility, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Beate NieslernCounter Core Facility, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7881-6112
Sven G MeuthUniversity Hospital Münster, Department of Neurology with Institute of Translational Neurology, 48149, Münster, Germany.
Christiane A OpitzJunior Group Brain Cancer Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-5575-9821
Jürgen G OkunCCU Children's Hospital and Metabolic Center Heidelberg, Heidelberg, Germany.
Christoph ReinhardtCenter for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-0696-2636
Florian C KurschusUniversity Medical Center of the Johannes Gutenberg-University Mainz, Institute for Molecular Medicine, Mainz, Germany.
Wolfgang WickDKTK Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6171-634X
Helge B BodeMolecular Biotechnology, Department of Biosciences and Buchmann Institute for Molecular Life Sciences (BMLS), Goethe-University Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-6048-5909
Philip RosenstielInstitute of Clinical Molecular Biology, University Kiel, Kiel, Germany.
Michael PlattenDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.platten@dkfz-heidelberg.de.ORCID http://orcid.org/0000-0002-4746-887X
German Cancer Research Center · DEInstitute of Molecular Biology · DEJohannes Gutenberg University Mainz · DEGoethe University Frankfurt · DEHeidelberg University · DEUniversity Hospital Münster · DEHopp Children's Cancer Center Heidelberg · DEMerck (Germany) · DERoche (Switzerland) · CHUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between the mammalian host and its resident gut microbiota is known to license adaptive immune responses. Nutritional constituents strongly influence composition and functional properties of the intestinal microbial communities. Here, we report that omission of a single essential amino acid - tryptophan - from the diet abrogates CNS autoimmunity in a mouse model of multiple sclerosis. Dietary tryptophan restriction results in impaired encephalitogenic T cell responses and is accompanied by a mild intestinal inflammatory response and a profound phenotypic shift of gut microbiota. Protective effects of dietary tryptophan restriction are abrogated in germ-free mice, but are independent of canonical host sensors of intracellular tryptophan metabolites. We conclude that dietary tryptophan restriction alters metabolic properties of gut microbiota, which in turn have an impact on encephalitogenic T cell responses. This link between gut microbiota, dietary tryptophan and adaptive immunity may help to develop therapeutic strategies for protection from autoimmune neuroinflammation.

Indexed as

DietTryptophanAnimalsAutoimmunityDietary ProteinsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalGastrointestinal MicrobiomeMiceMultiple SclerosisRNA, Ribosomal, 16ST-LymphocytesDietary ProteinsRNA, Ribosomal, 16STryptophan

Identifiers

PMID31653831
PMCPMC6814758
OpenAlexW2981974112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.